Replies to post #163171 on Cytodyn Inc (CYDY)

[misiu143]

CD10 , didnt fail , We SS in extremely important NEWS 2 endpoints , we reduced over 80% progression from moderate to severe ..
Lenzilumab is proud with 54% , we did it with over 80%.

And in CD12 , we SS in length of hospitalization ,, almost 6 days for S/C , that's a lot..and we the only one reducing mortality , SS in many subgroups ..

But FDA didn't approve the protocol as they did for Remdesivir and Lenzilumg , where we too could " PICK "

If we could " PICK " we be SS in both.

And I hope ALL HERE know that.

" Know what you own " is a nice saying...

And as our friend like to say ...

..." Sleep Well Shorts "..

All IMO.

[calstang66]

Boom Boom Boom. CYDY soon to rise rise rise.
Leronlimab is also looking good/great for HIV.
https://finance.yahoo.com/news/cytodyn-hiv-indication-leronlimab-hiv-130000387.html

[LifeLongLearner]

3X

If the previous CEO of CYDY was good, why didn’t he get the BLA approved? Is it a possibility in your mind that CYDY is not playing on a level playing field?

What other stock message board is buried in FUD like this one? Is that FUD the result of NP and the CRO or evidence of the poor condition of the field we find ourselves on?